Proton craniospinal irradiation with bevacizumab and pembrolizumab for leptomeningeal disease: a case report

Leptomeningeal disease (LMD) remains a challenging condition with a dismal prognosis. In this case study, we report partial response of LMD in a patient with metastatic large cell neuroendocrine carcinoma following treatment with proton craniospinal irradiation (CSI), bevacizumab, and pembrolizumab....

Descripción completa

Detalles Bibliográficos
Autores principales: Webb, Mason J, Breen, William G, Laack, Nadia N, Leventakos, Konstantinos, Campian, Jian L, Sener, Ugur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410687/
https://www.ncbi.nlm.nih.gov/pubmed/37491842
http://dx.doi.org/10.2217/cns-2023-0005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410687/
https://www.ncbi.nlm.nih.gov/pubmed/37491842
http://dx.doi.org/10.2217/cns-2023-0005

Ejemplares similares